JPY 937.0
(0.43%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 353.9 Billion JPY | -0.71% |
2022 | 356.43 Billion JPY | 4.69% |
2021 | 340.45 Billion JPY | 11.23% |
2020 | 306.07 Billion JPY | 12.26% |
2019 | 272.63 Billion JPY | 46.15% |
2018 | 186.54 Billion JPY | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 85.18 Billion JPY | -12.37% |
2023 Q4 | 97.21 Billion JPY | 8.18% |
2023 FY | 353.9 Billion JPY | -0.71% |
2023 Q3 | 89.86 Billion JPY | 5.11% |
2023 Q2 | 85.49 Billion JPY | 5.13% |
2023 Q1 | 81.32 Billion JPY | -10.96% |
2022 Q3 | 94.51 Billion JPY | 6.1% |
2022 Q1 | 81.5 Billion JPY | -7.47% |
2022 Q4 | 91.33 Billion JPY | -3.37% |
2022 FY | 356.43 Billion JPY | 4.69% |
2022 Q2 | 89.08 Billion JPY | 9.3% |
2021 FY | 340.45 Billion JPY | 11.23% |
2021 Q1 | 80.9 Billion JPY | -5.3% |
2021 Q3 | 86.31 Billion JPY | 1.38% |
2021 Q2 | 85.14 Billion JPY | 5.23% |
2021 Q4 | 88.08 Billion JPY | 2.05% |
2020 FY | 306.07 Billion JPY | 12.26% |
2020 Q2 | 75.09 Billion JPY | 19.94% |
2020 Q1 | 62.61 Billion JPY | 0.0% |
2020 Q3 | 82.92 Billion JPY | 10.42% |
2020 Q4 | 85.43 Billion JPY | 3.03% |
2019 FY | 272.63 Billion JPY | 46.15% |
2018 FY | 186.54 Billion JPY | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
DVx Inc. | 45.85 Billion JPY | -671.847% |
Seikagaku Corporation | 36.21 Billion JPY | -877.273% |
Eiken Chemical Co., Ltd. | 40.05 Billion JPY | -783.601% |
Create Medic Co., Ltd. | 12.58 Billion JPY | -2711.978% |
Techno Medica Co., Ltd. | 10.28 Billion JPY | -3341.318% |
Rion Co., Ltd. | 25.72 Billion JPY | -1275.598% |
Nihon Kohden Corporation | 221.98 Billion JPY | -59.424% |
Fukuda Denshi Co., Ltd. | 140.32 Billion JPY | -152.204% |
Japan Lifeline Co., Ltd. | 51.38 Billion JPY | -588.736% |
Japan Medical Dynamic Marketing, INC. | 23.17 Billion JPY | -1426.896% |
3-D Matrix, Ltd. | 4.58 Billion JPY | -7612.226% |
CYBERDYNE Inc. | 4.35 Billion JPY | -8028.158% |